DeepMind Reveals First Commercial Product
DeepMind, a British Artificial Intelligence company, has created a working prototype of a device that can diagnose complicated eye diseases in live time, in a major advancement towards the Alphabet-owned company’s first medical device.
In a real-time demonstration of its AI system, where a patient agreed to be examined publicly, DeepMind performed a retinal scan and live diagnosis of her eye. The scan was analysed by a series of algorithms in Google Cloud, which provided an urgency score and a detailed diagnosis, all in about 30 seconds. This system is able to detect a range of eye diseases — including glaucoma, diabetic retinopathy and age-related macular degeneration — with the same level of accuracy as the world’s leading specialists.
It was developed in conjunction with London’s Moorfields Eye Hospital over the previous three years, with details about the research published in Nature Medicine, the scientific journal, last August.
DeepMind claims its product will not only offer diagnoses, but will also be able to explain exactly how it arrived at its conclusion and how certain it is of the result, which is crucial for healthcare professionals.